Tirzepatide

Dual GIP/GLP-1 receptor agonist analogue

Tirzepatide is a dual GIP/GLP-1 receptor agonist analogue at the center of modern metabolic research programs. Available in 10 mg and 20 mg fills, verified at ≥ 99.1% purity with dual-receptor identity documentation.

Dual-incretin identity documentation
Purity ≥ 99.1% by HPLC
Sterile lyophilized format
Frequently paired with Semaglutide references

Choisir le format

98 $US1

84 vials of 10 mg in current lot · ships in 24 h cold-chain

Forme	Lyophilized powder · 3 mL amber vial
Contenu net	10 mg
Formats disponibles	10 mg · 20 mg
CAS	2023788-19-2
Masse molaire	4813.5 g/mol
Purity (HPLC)	≥ 99.1%
Conservation	Store at –20 °C. Cold-chain shipment included.

Depuis le laboratoire

Notes de recherche

Background reading on the analysis behind Tirzepatide’s certificate.

Analytics

Semaglutide vs. Tirzepatide: Comparing Mono-GLP-1 and Dual GLP-1/GIP Agonism in Laboratory Models

A technical comparison of Semaglutide vs. Tirzepatide in research models. Explore receptor kinetics, structural biochemistry, and laboratory reconstitution data.

22 January 20265 min de lecture Buying